Systematic screening reduces mortality, but is it the best way to go?
Lung cancer is the leading cause of cancer death in Australia. Late diagnosis of advanced disease contributes to the poor 13% 5-year survival rate associated with lung cancer. However, the recently updated United States National Lung Screening Trial (NLST) showed a 20% survival benefit from early detection with low-dose computed tomography (CT) screening.1,2 In light of these results, should people in Australia at high risk of lung cancer now undergo screening?
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.